| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.03 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.065 | 0.03 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.066 | 0.03 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.069 | 0.03 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.063 | 0.04 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.07 | 0.04 |